3D QSAR and pharmacophore study of curcuminoids and curcumin analogs: Interaction with thioredoxin reductase
- 1 December 2013
- journal article
- research article
- Published by Springer Nature in Interdisciplinary Sciences: Computational Life Sciences
- Vol. 5 (4) , 286-295
Abstract
Curcumin is the yellow pigment of Curcuma longa that irreversibly inhibits the activity of thioredoxin reductase (TrxR) and forms adduct. TrxR, a homodimeric enzyme with E and F chains, is responsible for redox control of the cell and defense against oxidative stress. It is also well known that TrxR is over-expressed in tumor cells. Hence TrxR is a promising target for curcumin based therapy. Binding site of TrxR for curcumin is at the interface of homodimers. In the present study, naturally occurring curcuminoids and forty four synthetic analogs of curcumin were docked with SP/XP glide suite and E-pharmacophore was simulated. E-pharmacophore of both chains has shown three donor features and one acceptor feature. 3D atom based QSAR models have been proposed for the two series of curcumin analogues of known IC50values. The data obtained indicates that the training set model is quite efficient to predict the test set of data. Obtained models and ADMET prediction could be employed for design and synthesis of more potent inhibitors of TrxR.Keywords
This publication has 11 references indexed in Scilit:
- Curcumin Conjugates Induce Apoptosis Via a Mitochondrion Dependent Pathway in MCF-7 and MDA-MB-231 Cell LinesAsian Pacific Journal of Cancer Prevention, 2013
- A plausible explanation for enhanced bioavailability of P-gp substrates in presence of piperine: simulation for next generation of P-gp inhibitorsJournal of Molecular Modeling, 2012
- Curcuminoids as inhibitors of thioredoxin reductase: A receptor based pharmacophore study with distance mapping of the active siteBioinformation, 2009
- Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitorsBioorganic & Medicinal Chemistry, 2008
- Inhibition of Thioredoxin Reductase by Curcumin AnalogsBioscience, Biotechnology, and Biochemistry, 2008
- Metabolism and Anticancer Activity of the Curcumin Analogue, DimethoxycurcuminClinical Cancer Research, 2007
- From Ancient Medicine to Modern Medicine: Ayurvedic Concepts of Health and Their Role in Inflammation and CancerJournal of the Society for Integrative Oncology, 2007
- PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary resultsJournal of Computer-Aided Molecular Design, 2006
- Thioredoxin Reductase Is Irreversibly Modified by CurcuminJournal of Biological Chemistry, 2005
- Thioredoxin reductase as a pathophysiological factor and drug targetEuropean Journal of Biochemistry, 2000